TY - JOUR
T1 - Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement
AU - Sheikh, Muhammad Adil
AU - Deo, Salil V.
AU - Riaz, Haris
AU - Raza, Sajjad
AU - Altarabsheh, Salah E.
AU - Wilson, Brigid
AU - Elgudin, Yakov
AU - Cmolik, Brian
AU - Pelletier, Marc
AU - Markowitz, Alan H.
N1 - Publisher Copyright:
© 2020 Wiley Periodicals LLC.
PY - 2021/2/15
Y1 - 2021/2/15
N2 - Objective: To compare post-procedural outcomes of trans-catheter valve replacement (TAVR) among safety-net (SNH) and non-safety net hospitals (non-SNH). Background: SNH treat a large population of un-insured and low income patients; prior studies report worse outcome at these centers. Results of TAVR at these centers is limited. Methods: Adults undergoing TAVR at hospitals in the US participating in the National In-patient sample (NIS) database from January 2014 to December 2015 were included. A 1:1 propensity-matched cohort of patients operated at SNH and non-SNH institutions was analyzed, on the basis of 16 demographic and clinical co-variates. Main outcome was all-cause post-procedural mortality. Secondary outcomes included stroke, acute kidney injury and length of post-operative stay. Results: Between 2014 and 2015, 41,410 patients (mean age 80 ± 0.11 years, 46% female) underwent TAVR at 731 centers; 6,996 (16.80%) procedures were performed at SNH comprising 135/731 (18.4%) of all centers performing TAVR. SNH patients were more likely to be female (49% vs. 46%, p <.001); admitted emergently (31% vs. 21%; p <.001; at the lowest quartile for household income (25% % vs. 20%; p <.001) and from minorities (Blacks 5.9% vs. 3.9%; Hispanic 7.2% vs. 3.2%).Adjusted logistic regression was performed on 6,995 propensity-matched patient pairs. Post-procedural mortality [OR 0.99(0.98–1.007); p =.43], stroke [OR 1.009(0.99–1.02); p =.08], acute kidney injury [OR 0.99(0.96–1.01); p =.5] and overall length of stay (6.9 ± 0.1 vs. 7.1 ± 0.2 days; p =.57) were comparable in both cohorts. Conclusion: Post-procedural outcomes after TAVR at SNH are comparable to national outcomes and wider adoption of TAVR at SNH may not adversely influence outcomes.
AB - Objective: To compare post-procedural outcomes of trans-catheter valve replacement (TAVR) among safety-net (SNH) and non-safety net hospitals (non-SNH). Background: SNH treat a large population of un-insured and low income patients; prior studies report worse outcome at these centers. Results of TAVR at these centers is limited. Methods: Adults undergoing TAVR at hospitals in the US participating in the National In-patient sample (NIS) database from January 2014 to December 2015 were included. A 1:1 propensity-matched cohort of patients operated at SNH and non-SNH institutions was analyzed, on the basis of 16 demographic and clinical co-variates. Main outcome was all-cause post-procedural mortality. Secondary outcomes included stroke, acute kidney injury and length of post-operative stay. Results: Between 2014 and 2015, 41,410 patients (mean age 80 ± 0.11 years, 46% female) underwent TAVR at 731 centers; 6,996 (16.80%) procedures were performed at SNH comprising 135/731 (18.4%) of all centers performing TAVR. SNH patients were more likely to be female (49% vs. 46%, p <.001); admitted emergently (31% vs. 21%; p <.001; at the lowest quartile for household income (25% % vs. 20%; p <.001) and from minorities (Blacks 5.9% vs. 3.9%; Hispanic 7.2% vs. 3.2%).Adjusted logistic regression was performed on 6,995 propensity-matched patient pairs. Post-procedural mortality [OR 0.99(0.98–1.007); p =.43], stroke [OR 1.009(0.99–1.02); p =.08], acute kidney injury [OR 0.99(0.96–1.01); p =.5] and overall length of stay (6.9 ± 0.1 vs. 7.1 ± 0.2 days; p =.57) were comparable in both cohorts. Conclusion: Post-procedural outcomes after TAVR at SNH are comparable to national outcomes and wider adoption of TAVR at SNH may not adversely influence outcomes.
KW - aortic valve disease
KW - health care outcomes
KW - transcatheter valve implantation
UR - http://www.scopus.com/inward/record.url?scp=85088095972&partnerID=8YFLogxK
U2 - 10.1002/ccd.29123
DO - 10.1002/ccd.29123
M3 - Article
C2 - 32681697
AN - SCOPUS:85088095972
SN - 1522-1946
VL - 97
SP - E425-E430
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
IS - 3
ER -